We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Innosis Ecological Ag | TG:IVX | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
Hot Features
Premium
IVAX Corporation
IVAX Launches Amoxicillin With Clavulanate Potassium
IVAX Corporation (AMEX:IVX) (LSE:IVX.L) announced that its wholly
owned subsidiary, IVAX Pharmaceuticals, Inc. is distributing
amoxicillin with clavulanate potassium, supplied and licensed by
GlaxoSmithKline (LSE and NYSE:GSK). Amoxicillin with clavulnate
potassium is an oral antibacterial combination used for the treatment
of respiratory, urinary and skin infections; and is the generic
equivalent of Augmentin(R), which is marketed by GlaxoSmithKline. U.S.
sales for amoxicillin with clavulanate potassium were $1.4 billion for
the twelve months ending September 30, 2003.
IVAX Corporation, headquartered in Miami, Florida, discovers,
develops, manufactures, and markets branded and brand equivalent
(generic) pharmaceuticals and veterinary products in the U.S. and
internationally.
Copies of this and other news releases may be obtained free of
charge from IVAX' website at http://www.ivax.com.
1 Year Innosis Ecological Chart |
1 Month Innosis Ecological Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
